182 related articles for article (PubMed ID: 35216581)
41. Metabolic Acidosis and CKD Progression.
Madias NE
Clin J Am Soc Nephrol; 2021 Feb; 16(2):310-312. PubMed ID: 32769096
[No Abstract] [Full Text] [Related]
42. Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study.
Kendrick J; Shah P; Andrews E; You Z; Nowak K; Pasch A; Chonchol M
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1463-1470. PubMed ID: 30237219
[TBL] [Abstract][Full Text] [Related]
43. Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease.
Hultin S; Johnson DW; Badve SV
Curr Opin Nephrol Hypertens; 2021 Sep; 30(5):467-473. PubMed ID: 34009141
[TBL] [Abstract][Full Text] [Related]
44. The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients.
Bayram D; Tuğrul Sezer M; İnal S; Altuntaş A; Kıdır V; Orhan H
Clin Exp Nephrol; 2015 Jun; 19(3):443-9. PubMed ID: 25082656
[TBL] [Abstract][Full Text] [Related]
45. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
Goraya N; Simoni J; Jo CH; Wesson DE
Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
[TBL] [Abstract][Full Text] [Related]
46. Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease: Rationale and Design of the NEUTRALIZE Study.
Ash SR; Batlle D; Kendrick J; Oluwatosin Y; Pottorf W; Brahmbhatt Y; Guerrieri E; Fried L
Nephron; 2022; 146(6):599-609. PubMed ID: 35462371
[TBL] [Abstract][Full Text] [Related]
47. A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?
Bodker K; Freidin N; Arora N
Curr Opin Nephrol Hypertens; 2024 May; 33(3):304-310. PubMed ID: 38420899
[TBL] [Abstract][Full Text] [Related]
48. Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment.
Kim HJ
Electrolyte Blood Press; 2021 Dec; 19(2):29-37. PubMed ID: 35003283
[TBL] [Abstract][Full Text] [Related]
49. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
[TBL] [Abstract][Full Text] [Related]
50. Effect of metabolic acidosis on QT intervals in patients with chronic kidney disease.
Yenigun EC; Aypak C; Turgut D; Aydin MZ; Dede F
Int J Artif Organs; 2016 Aug; 39(6):272-6. PubMed ID: 27515860
[TBL] [Abstract][Full Text] [Related]
51. Current status of bicarbonate in CKD.
Dobre M; Rahman M; Hostetter TH
J Am Soc Nephrol; 2015 Mar; 26(3):515-23. PubMed ID: 25150154
[TBL] [Abstract][Full Text] [Related]
52. Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.
Aigner C; Cejka D; Sliber C; Fraunschiel M; Sunder-Plassmann G; Gaggl M
Kidney Blood Press Res; 2019; 44(2):188-199. PubMed ID: 31067546
[TBL] [Abstract][Full Text] [Related]
53. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review.
Susantitaphong P; Sewaralthahab K; Balk EM; Jaber BL; Madias NE
Am J Nephrol; 2012; 35(6):540-7. PubMed ID: 22653322
[TBL] [Abstract][Full Text] [Related]
54. Serum bicarbonate concentrations and kidney disease progression in community-living elders: the Health, Aging, and Body Composition (Health ABC) Study.
Goldenstein L; Driver TH; Fried LF; Rifkin DE; Patel KV; Yenchek RH; Harris TB; Kritchevsky SB; Newman AB; Sarnak MJ; Shlipak MG; Ix JH;
Am J Kidney Dis; 2014 Oct; 64(4):542-9. PubMed ID: 24953890
[TBL] [Abstract][Full Text] [Related]
55. Sodium citrate versus sodium bicarbonate for metabolic acidosis in patients with chronic kidney disease: A randomized controlled trial.
Sorohan BM; Obrișcă B; Jurubiță R; Lupușoru G; Achim C; Andronesi A; Frățilă G; Berechet A; Micu G; Ismail G
Medicine (Baltimore); 2024 Mar; 103(10):e37475. PubMed ID: 38457574
[TBL] [Abstract][Full Text] [Related]
56. Approach to the Treatment of Chronic Metabolic Acidosis in CKD.
Raphael KL
Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease.
Raphael KL; Zhang Y; Ying J; Greene T
Nephrology (Carlton); 2014 Oct; 19(10):648-54. PubMed ID: 25066359
[TBL] [Abstract][Full Text] [Related]
58. A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study.
Di Iorio B; Aucella F; Conte G; Cupisti A; Santoro D
J Nephrol; 2012; 25(3):437-40. PubMed ID: 21928233
[TBL] [Abstract][Full Text] [Related]
59. Acid Load and Phosphorus Homeostasis in CKD.
Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
[TBL] [Abstract][Full Text] [Related]
60. Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis.
Navaneethan SD; Shao J; Buysse J; Bushinsky DA
Clin J Am Soc Nephrol; 2019 Jul; 14(7):1011-1020. PubMed ID: 31196951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
